The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer

被引：13
作者：
Sivalingam, S [1 ]
Probert, JL [1 ]
Schwaibold, H [1 ]
机构：
[1] Southmead Gen Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England
来源：
BJU INTERNATIONAL | 2005年 / 96卷 / 06期
关键词：
transitional cell bladder cancer; superficial bladder cancer; high-risk bladder cancer; transurethral resection; re-resection;
D O I：
10.1111/j.1464-410X.2005.05710.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：759 / 762
页数：4
相关论文
共 50 条
  • [21] Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma
    Li, Liao-Yuan
    Yang, Ming
    Zhang, Hai-Bin
    Su, Xi-Kang
    Xu, Wen-Feng
    Chen, Yong
    Shen, Zhou-Jun
    Gao, Xin
    BJU INTERNATIONAL, 2008, 102 (05) : 566 - 571
  • [22] The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer
    Russell, Christopher M.
    Lebastchi, Amir H.
    Borza, Tudor
    Spratt, Daniel E.
    Morgan, Todd M.
    BLADDER CANCER, 2016, 2 (04) : 381 - 394
  • [23] The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System
    Nakamura, Yuki
    Yoshida, Soichiro
    Arita, Yuki
    Takeshita, Ryo
    Kimura, Koichiro
    Kobayashi, Masaki
    Fujiwara, Motohiro
    Ishikawa, Yudai
    Fukuda, Shohei
    Waseda, Yuma
    Tanaka, Hajime
    Jinzaki, Masahiro
    Fujii, Yasuhisa
    INTERNATIONAL JOURNAL OF UROLOGY, 2025, 32 (03) : 264 - 269
  • [24] High-Risk Nonmuscle Invasive Bladder Cancer
    Orsola, Anna
    Palou, Joan
    Solsona, Eduardo
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (02) : 227 - +
  • [25] Usefulness of urinary NMP22 to detect tumor recurrence of superficial bladder cancer after transurethral resection
    Naoto Miyanaga
    Hideyuki Akaza
    Sadamu Tsukamoto
    Toru Shimazui
    Mikinobu Ohtani
    Satoru Ishikawa
    Ryosuke Noguchi
    Fumio Manabe
    Yukiko Nishijima
    Koji Kikuchi
    Ken Sato
    Hitoshi Hayashi
    Fukuji Kondo
    Hiroshi Shiraiwa
    Osamu Aoyama
    International Journal of Clinical Oncology, 2003, 8 (6) : 369 - 373
  • [26] Treatment options for high-risk T1 bladder cancer
    Weiss, Christian
    Ott, Oliver J.
    Wittlinger, Michael
    Krause, Steffen F.
    Fietkau, Rainer
    Sauer, Rolf
    Roedel, Claus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (09) : 443 - 449
  • [27] Treatment of high-risk superficial bladder cancer with maintenance bacille Calmette-Guerin therapy: preliminary results
    Kolodziej, A
    Dembowski, J
    Zdrojowy, R
    Wozniak, P
    Lorenz, J
    BJU INTERNATIONAL, 2002, 89 (06) : 620 - 622
  • [28] Transurethral resection of superficial bladder cancer using 5-aminolevulinic acid: are there any long-term benefits?
    White, RWD
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (05): : 254 - 255
  • [29] Limited significance of routine excretory urography in the follow-up of patients with superficial bladder cancer after transurethral resection
    Miyake, H
    Hara, I
    Yamanaka, K
    Inoue, TA
    Fujisawa, M
    BJU INTERNATIONAL, 2006, 97 (04) : 720 - 723
  • [30] Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer
    Cobo M.
    Delgado R.
    Gil S.
    Herruzo I.
    Baena Víctor
    Carabante F.
    Moreno P.
    Ruiz J.L.
    Bretón J.J.
    del Rosal J.M.
    Fuentes C.
    Moreno P.
    García E.
    Villar E.
    Contreras J.
    Alés I.
    Benavides M.
    Clinical and Translational Oncology, 2006, 8 (12) : 903 - 911
12345